Prevalence and risk factors of abnormally high N-terminal pro B-type natriuretic peptide (NT-proBNP) in diabetes patients with high risk for diabetic foot ulcer.

Roche Diagnostics (Thailand) Limited0 个研究点目标入组 82 人开始时间: 2024年4月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.High risk diabetic foot ulcers patients : diagnosis criteria
•-Loss of Protective Sensation or Peripheral Artery Disease and one or more of the following:
•- history of a foot ulcer and there is a foot ulcer, the ulcer must not have an active infection.
•- a lower-extremity amputation (minor or major)
•2.Age is over 18 years old.

•1.History of heart disease
•-myocardium infarction
•- heart failure or symptomatic of heart failure
•- constrictive pericarditis
•-cardiac tamponade
•-valvular heart disease
•-hypertrophic cardiomyopathy
•-persistent cardiac arrhythmias
•2.eGFR calculated by CKD-EPI < 30 ml/min/1.732
•3.Hb < 8 gm/dl
•4.Assay interference
•If one receives medication or levels of substances that exceed the specified threshold, it may affect the NT-proBNP test results.
•-Bilirubin > 25 mg/dL
•-fasting triglyceride > 1500 mg/dL
•- Individuals who are taking medication containing biotin.
•- Rheumatoid arthritis, TB, connective tissue disease, hematologic malignancy

发起方

Roche Diagnostics (Thailand) Limited